Showing results (1111-1120 of 1,157) with videos related to

Sort By:
Pageof 116
Carcinogenesis|June 25, 2015
Disruptive chemicals, senescence and immortalityAmancio Carnero, Carmen Blanco-Aparicio, Hiroshi Kondoh, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation DetectionMarco Macagno, Valeria Pessei, Noemi Congiusta, et al.
Minerva Anestesiologica|July 28, 2010
Postoperative pain treatment SIAARTI Recommendations 2010. Short versionG Savoia, D Alampi, B Amantea, et al.
Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.
Blood Advances|January 7, 2026
POD24 is a Novel Determinant of Prognosis in Patients with Waldenström MacroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Shirley D'Sa, et al.
Hemasphere|January 30, 2023
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular LymphomaReid W Merryman, Laure Michaud, Robert Redd, et al.
Research Square|February 6, 2026
Dysregulation of human ClpP using small molecules with piperazine-based scaffold for diffuse intrinsic pontine glioma therapy validated by patient-derived tumor organoidsAntonio Scilimati, Morena Miciaccia, Domenico Armenise, et al.
Nature|January 22, 2025
Regional and institutional trends in assessment for academic promotionB H Lim, C D'Ippoliti, M Dominik, et al.
Carcinogenesis|June 25, 2015
The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signallingWilhelm Engström, Philippa Darbre, Staffan Eriksson, et al.
Blood Cancer Journal|August 8, 2025
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohortsPatrizia Mondello, Brianna Negaard, Andrew L Feldman, et al.
Pageof 116